alzheimer - MeSH

Search results

Items: 1 to 20 of 35

<< First< Prev

Page of 2

Select item 680005441.

A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Year introduced: 1998(1963)

Select item 680235822.

Alzheimer Vaccines

Vaccines or candidate vaccines used to prevent or treat ALZHEIMER DISEASE.

Year introduced: 2002

Select item 675365983.

Alzheimer disease, familial, type 3 [Supplementary Concept]

Date introduced: August 25, 2010

Select item 675365954.

Alzheimer disease type 2 [Supplementary Concept]

Date introduced: August 25, 2010

Select item 680162295.

Amyloid beta-Peptides

Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.

Year introduced: 1991

Select item 675365966.

Alzheimer disease type 4 [Supplementary Concept]

Date introduced: August 25, 2010

Select item 675365947.

Alzheimer disease type 1 [Supplementary Concept]

Date introduced: August 25, 2010

Select item 674062388.

fetal Alzheimer antigen [Supplementary Concept]

FAC1 - Fetal Alz-50-Reactive Clone 1; located both in nucleus and cytoplasm of cells of the developing cortex

Date introduced: April 7, 2000

Select item 675670229.